Aeolus Pharma Revenue, Profits - AOLS Annual Income Statement

Add to My Stocks
$0 $0 (0%) AOLS stock closing price Sep 18, 2018 (Closing)

Financial analysis of Aeolus Pharma involves more than just checking the Aeolus Pharma stock price, by looking at the financial statements of the company in detail. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $2.07M for 2016 impacts the AOLS stock. Investors typically check year over year or quarter over quarter revenue growth. The Aeolus Pharma profit and loss statement for 2016 shows a net profit of $-3.55M. Profits for last year was $-2.62M. Apart from this an investor should also check Aeolus Pharma assets and Aeolus Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Oct - Sep201620152014201320122011201020092008
Aeolus Pharma Revenues or Net Sales
2.07M3.11M9.63M3.92M7.29M4.82M---
Cost Of Goods Sold (COGS)---------
Aeolus Pharma Gross Profit
2.07M3.11M9.63M3.92M7.29M4.82M---
Research & Development Expense2.88M3.5M6.96M3.36M6.46M5.05M1.69M--
Selling General & Admin Expense2.46M2.22M2.74M3.26M3.19M3.66M1.95M1.29M1.54M
Income Before Depreciation Depletion Amortization-3.27M-2.62M-0.08M-2.69M-2.37M-3.9M-3.64M-2M-2.51M
Depreciation Depletion Amortization---------
Non Operating Income----0.51M4.06M4.22M-21.34M--0.36M
Interest Expense---------
Aeolus Pharma Pretax Income
-3.55M-2.62M-0.08M-3.2M1.69M--25.86M-2.29M-2.97M
Provision for Income Taxes---------
MinorityInterest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-3.55M-2.62M-0.08M-3.2M1.69M--25.86M-2.29M-2.97M
Extraordinary Items & Discontinued Operations---------
Aeolus Pharma Profit/ Loss (Net Income)
-3.55M-2.62M-0.08M-3.2M1.69M--25.86M-2.29M-2.97M
Average Shares used to compute Diluted EPS148.67M135.88M134.67M106.55M72.75M82.3M49.15M34.79M32.22M
Average Shares used to compute Basic EPS148.67M135.88M134.67M106.55M61.59M59.47M49.15M34.79M31.95M
Income Before Nonrecurring Items-3.56M-2.63M-0.08M-2.7M-2.37M-4.19M-9.23M-2.3M-2.97M
Income from Nonrecurring Items----0.51M4.07M3.89M-16.64M--
Aeolus Pharma Earnings Per Share Basic Net
-0.04-0.020.00-0.030.03-0.01-0.53-0.07-0.09
Aeolus Pharma Earnings Per Share Diluted Net
-0.04-0.020.00-0.030.020.00-0.53-0.07-0.11
EPS Diluted Before Nonrecurring Items-0.04-0.020.00-0.03-0.04-0.05-0.19-0.07-0.11
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing Aeolus Pharma stock analysis are:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that AOLS stock has a topline or revenue of $2.07M for 2016 as per this Aeolus Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: Most businesses like Aeolus Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The AOLS financials along with Aeolus Pharma historical stock prices provide a lot of details about the firm.

Aeolus Pharma Income Statement - Key Financial Ratios